New oral lesion by regorafenib: A case report
Oral Dis
.
2023 Jan;29(1):337-338.
doi: 10.1111/odi.14208.
Epub 2022 Apr 19.
Authors
Francesca Spirito
1
,
Mario Caggiano
1
,
Laura Sisalli
1
,
Federica Di Spirito
1
,
Massimo Amato
1
Affiliation
1
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
PMID:
35403798
DOI:
10.1111/odi.14208
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Antineoplastic Agents* / adverse effects
Humans
Phenylurea Compounds* / therapeutic use
Pyridines / adverse effects
Substances
regorafenib
Phenylurea Compounds
Pyridines
Antineoplastic Agents